StonvexLoading…
StonvexStonvexStonvexCore line items from EXPO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q2 2026 2026-04-03 | Annual 2026 2026-01-02 | Q4 2025 2025-10-03 | Q3 2025 2025-07-04 |
|---|---|---|---|---|---|
Revenue | $150.50M | $166.30M | $582.01M | $434.59M | $287.47M |
Operating Income | Not available | $41.38M | $119.79M | $90.65M | $61.61M |
Net Income | Not available | $29.57M | $106.01M | $81.25M | $53.20M |
EPS (Diluted) | $0.56 | $0.59 | $2.07 | $1.58 | $1.03 |
Total Assets | Not available | $687.38M | $777.52M | $761.45M | $759.43M |
Total Liabilities | Not available | $349.04M | $387.18M | $358.59M | $331.65M |
Cash & Equivalents | Not available | $118.55M | $221.93M | $207.38M | $231.80M |
Free Cash Flow OCF − CapEx | Not available | $-3.43M | $122.34M | $69.44M | $39.47M |
Shares Outstanding | Not available | 50.12M | 51.24M | 51.45M | 51.59M |